A team of researchers at McMaster University is working on an inhaled COVID-19 vaccine that offers better protection and is less costly to produce, store and ship.
Vaccine development will play a tremendous role in warding off the next pandemic, says Matthew Miller, Director of the Michael G. DeGroote Institute for Infectious Disease Research.
The findings could inform new approaches to protecting high-risk groups, including the elderly and children during an emerging influenza pandemic, say the study's researchers.
McMaster logo
McMaster logo
